Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-Mouse IL-17A Antibody (17F3)
Catalog No. T9901A-501 Copy Product Info
🥰Excellent
Anti-Mouse IL-17A Antibody (17F3) is an antibody designed specifically to inhibit mouse IL-17A.
Anti-Mouse IL-17A Antibody (17F3)
Copy Product Info🥰Excellent
Catalog No. T9901A-501
Anti-Mouse IL-17A Antibody (17F3) is an antibody designed specifically to inhibit mouse IL-17A.
Anti-Mouse IL-17A Antibody
(17F3)
(17F3)
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $98 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:97.0% (SDS-PAGE); 99.1% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Anti-Mouse IL-17A Antibody (17F3) is an antibody designed specifically to inhibit mouse IL-17A. |
| In vivo | Methods: To investigate the anti-inflammatory effects of Anti-Mouse IL-17A Antibody (17F3), mice in a model of intracellular Mycobacterium infection were administered intraperitoneal injections of Anti-Mouse IL-17A Antibody (17F3) (100 μg, every other day) for 11 consecutive days. Results: Anti-Mouse IL-17A Antibody (17F3) demonstrated significant anti-infective effects. [1] Methods: In a mouse model treated with immune checkpoint inhibitors (ICI), Anti-Mouse IL-17A Antibody (17F3) (0.5 mg/dose, intraperitoneal injection) was administered three times weekly. Results: Anti-Mouse IL-17A Antibody (17F3) reduced autoimmune infiltration in a mouse model treated with immune checkpoint inhibitors (ICI). [2] Methods: To investigate the role of Anti-Mouse IL-17A Antibody (17F3) in diabetic nephropathy, a streptozotocin-induced diabetic nephropathy mouse model was used. Anti-Mouse IL-17A Antibody (17F3) (200 μg, twice weekly) was administered intraperitoneally until week 12. Results: Anti-Mouse IL-17A Antibody (17F3) exerts a protective effect against diabetic nephropathy in streptozotocin-induced diabetic mice.[3] |
| Clone | 17F3 |
| Reactivity | Mouse |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | IL-17A |
| Molecular Weight | 145.79 kDa |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | Store at -20°C Shipping with blue ice. |
Citations
Calculator
Preview
Related Tags: buy Anti-Mouse IL-17A Antibody (17F3) | purchase Anti-Mouse IL-17A Antibody (17F3) | Anti-Mouse IL-17A Antibody (17F3) cost | order Anti-Mouse IL-17A Antibody (17F3) | Anti-Mouse IL-17A Antibody (17F3) in vivo | Anti-Mouse IL-17A Antibody (17F3) molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.